Evidence map›Paper›PMID 36788210›Full record

ArticleNature communications2023

On-demand male contraception via acute inhibition of soluble adenylyl cyclase.

Melanie Balbach, Thomas Rossetti, Jacob Ferreira, Lubna Ghanem, Carla Ritagliati, Robert W Myers, David J Huggins, Clemens Steegborn, Ileana C Miranda, Peter T Meinke and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 75 citations in OpenAlex.

  1. Novel male contraceptives.Future science OA · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Small-molecule modulators of HIPK4 activity and proteostasis.bioRxiv : the preprint server for biology · 2026
    Article
  7. Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. [Male contraception-scientific foundations and contemporary progress].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Melanie BalbachDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Thomas RossettiDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Jacob FerreiraDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Lubna GhanemDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Carla RitagliatiDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Robert W MyersTri-Institutional Therapeutics Discovery Institute, New York, NY, USA.
David J HugginsTri-Institutional Therapeutics Discovery Institute, New York, NY, USA.
Clemens SteegbornDepartment of Biochemistry, University of Bayreuth, Bayreuth, Germany.ORCID 0000-0002-0913-1467
Ileana C MirandaLaboratory of Comparative Pathology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and The Rockefeller University, New York, NY, USA.ORCID 0000-0003-3168-0515
Peter T MeinkeDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Jochen BuckDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA. jobuck@med.cornell.edu.ORCID 0000-0002-3568-5869
Lonny R LevinDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-5204-6356
Cornell University · USMemorial Sloan Kettering Cancer Center · USTri-Institutional Therapeutics Discovery Institute · USUniversity of Bayreuth · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Crosstalk between metabolic and signaling pathways involved in sperm capacitationR01HD088571 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI JOCHEN BUCK, LONNY R LEVIN · 2017 to 2026
$6.1M
Optimization and pre-clinical evaluation of ADCY10 inhibitorsP50HD100549 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVIN, LONNY R · 2019 to 2021
$6.0M
Discovery and Characterization of an Endogenous Inhibitor of Soluble Adenylyl CyclaseF31HD105363 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI FERREIRA, JACOB · 2021 to 2023
$140k
Activation of Soluble Adenylyl Cyclase as a Novel Therapeutic Strategy for the Treatment of Age-Related Neurodegenerative DisordersF31AG069501 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROSSETTI, THOMAS · 2020 to 2022
$129k
NCI NIH HHS P30 CA008748NIA NIH HHS F31 AG069501NICHD NIH HHS F31 HD105363NICHD NIH HHS P50 HD100549NICHD NIH HHS R01 HD088571
6 · The paper itself

Abstract

Nearly half of all pregnancies are unintended; thus, existing family planning options are inadequate. For men, the only choices are condoms and vasectomy, and most current efforts to develop new contraceptives for men impact sperm development, meaning that contraception requires months of continuous pretreatment. Here, we provide proof-of-concept for an innovative strategy for on-demand contraception, where a man would take a birth control pill shortly before sex, only as needed. Soluble adenylyl cyclase (sAC) is essential for sperm motility and maturation. We show a single dose of a safe, acutely-acting sAC inhibitor with long residence time renders male mice temporarily infertile. Mice exhibit normal mating behavior, and full fertility returns the next day. These studies define sAC inhibitors as leads for on-demand contraceptives for men, and they provide in vivo proof-of-concept for previously untested paradigms in contraception; on-demand contraception after just a single dose and pharmacological contraception for men.

Indexed as

Adenylyl Cyclase InhibitorsAdenylyl CyclasesContraceptive Agents, MaleAnimalsContraceptionFemaleHumansMaleMicePregnancySemenSperm MotilityAdenylyl Cyclase InhibitorsAdenylyl CyclasesContraceptive Agents, Male

Identifiers

PMID36788210
PMCPMC9929232
OpenAlexW4320856717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.